Altitude-related hypoxia: risk assessment and management for passengers on commerical aircraft.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 14503669)

Published in Aviat Space Environ Med on September 01, 2003

Authors

Amir Mortazavi1, Mark J Eisenberg, David Langleben, Pierre Ernst, Renee L Schiff

Author Affiliations

1: Division of Cardiology, McGill University, Montreal, Quebec, Canada.

Articles by these authors

Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol (2009) 12.05

Clinical classification of pulmonary hypertension. J Am Coll Cardiol (2004) 5.87

Riociguat for the treatment of pulmonary arterial hypertension. N Engl J Med (2013) 5.60

The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol (2010) 5.54

ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association: developed in collaboration with the American College of Chest Physicians, American Thoracic Society, Inc., and the Pulmonary Hypertension Association. Circulation (2009) 5.49

ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol (2007) 5.40

Use of high potency statins and rates of admission for acute kidney injury: multicenter, retrospective observational analysis of administrative databases. BMJ (2013) 4.90

ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). Circulation (2007) 4.66

Gait speed as an incremental predictor of mortality and major morbidity in elderly patients undergoing cardiac surgery. J Am Coll Cardiol (2010) 4.53

Long-term natural history of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax (2012) 4.06

Warfarin use and the risk for stroke and bleeding in patients with atrial fibrillation undergoing dialysis. Circulation (2014) 3.78

Mortality rates in elderly patients who take different angiotensin-converting enzyme inhibitors after acute myocardial infarction: a class effect? Ann Intern Med (2004) 3.62

Inhaled corticosteroids in COPD and the risk of serious pneumonia. Thorax (2013) 3.62

Adult Asthma Consensus Guidelines update 2003. Can Respir J (2004) 3.61

A hierarchical Bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet (2004) 3.52

Statins for secondary prevention in elderly patients: a hierarchical bayesian meta-analysis. J Am Coll Cardiol (2008) 3.43

Increased risk of childhood asthma from antibiotic use in early life. Chest (2007) 3.11

Rhythm versus rate control therapy and subsequent stroke or transient ischemic attack in patients with atrial fibrillation. Circulation (2012) 2.96

Meta-analysis of efficacy and safety of new oral anticoagulants (dabigatran, rivaroxaban, apixaban) versus warfarin in patients with atrial fibrillation. Am J Cardiol (2012) 2.76

Cardiac medical therapy in patients after undergoing coronary artery bypass graft surgery: a review of randomized controlled trials. J Am Coll Cardiol (2005) 2.75

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. J Am Coll Cardiol (2008) 2.67

Bronchodilator use and the risk of arrhythmia in COPD: part 1: Saskatchewan cohort study. Chest (2012) 2.65

Sitaxsentan therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med (2003) 2.64

Treatment of pulmonary arterial hypertension with the selective endothelin-A receptor antagonist sitaxsentan. J Am Coll Cardiol (2006) 2.42

Should combination therapy with inhaled corticosteroids and long-acting beta2-agonists be prescribed as initial maintenance treatment for asthma? CMAJ (2002) 2.30

Effectiveness of renal denervation therapy for resistant hypertension: a systematic review and meta-analysis. J Am Coll Cardiol (2013) 2.29

Adjunctive thrombectomy for acute myocardial infarction: A bayesian meta-analysis. Circ Cardiovasc Interv (2010) 2.27

Role of frailty in patients with cardiovascular disease. Am J Cardiol (2009) 2.19

Preoperative anxiety as a predictor of mortality and major morbidity in patients aged >70 years undergoing cardiac surgery. Am J Cardiol (2013) 2.18

Fluoroquinolones and the risk of serious arrhythmia: a population-based study. Clin Infect Dis (2012) 2.17

The cardiovascular effects of peroxisome proliferator-activated receptor agonists. Am J Med (2012) 2.15

Alternative smoking cessation aids: a meta-analysis of randomized controlled trials. Am J Med (2012) 2.06

Cardiovascular morbidity and mortality in COPD. Chest (2005) 2.01

Off-pump vs. on-pump coronary artery bypass surgery: an updated meta-analysis and meta-regression of randomized trials. Eur Heart J (2011) 1.96

Coronary artery disease in the developing world. Am Heart J (2004) 1.95

Comparative effectiveness of rhythm control vs rate control drug treatment effect on mortality in patients with atrial fibrillation. Arch Intern Med (2012) 1.94

Bleeding complications associated with combinations of aspirin, thienopyridine derivatives, and warfarin in elderly patients following acute myocardial infarction. Arch Intern Med (2005) 1.91

Meta-analysis of ten trials on the effectiveness of the radial versus the femoral approach in primary percutaneous coronary intervention. Am J Cardiol (2011) 1.91

Underreporting exacerbation of chronic obstructive pulmonary disease in a longitudinal cohort. Am J Respir Crit Care Med (2007) 1.85

Agricultural subsidies and the American obesity epidemic. Am J Prev Med (2013) 1.83

Efficacy of exercise-based cardiac rehabilitation post-myocardial infarction: a systematic review and meta-analysis of randomized controlled trials. Am Heart J (2011) 1.82

A comparison of brand-name drug prices between Canadian-based Internet pharmacies and major U.S. drug chain pharmacies. Ann Intern Med (2005) 1.80

Gender differences in survival following hospitalisation for COPD. Thorax (2010) 1.73

Selective endothelin A receptor antagonism with sitaxsentan for pulmonary arterial hypertension associated with connective tissue disease. Ann Rheum Dis (2007) 1.72

Meta-analysis of usefulness of d-dimer to diagnose acute aortic dissection. Am J Cardiol (2011) 1.70

The use of inhaled corticosteroids and the risk of adrenal insufficiency. Eur Respir J (2012) 1.67

Inhaled corticosteroids and the risks of diabetes onset and progression. Am J Med (2010) 1.66

Canadian Pediatric Asthma Consensus guidelines, 2003 (updated to December 2004): introduction. CMAJ (2005) 1.63

High prevalence of occult left heart disease in scleroderma-pulmonary hypertension. Eur Respir J (2012) 1.62

Safety of laparoscopic vs open bariatric surgery: a systematic review and meta-analysis. Arch Surg (2011) 1.58

Effects of early and late administration of angiotensin-converting enzyme inhibitors on mortality after myocardial infarction. Am J Med (2003) 1.54

Meta-analysis of rivaroxaban and bleeding risk. Am J Cardiol (2013) 1.53

Class effects of statins in elderly patients with congestive heart failure: a population-based analysis. Am Heart J (2007) 1.53

Myocardial laser revascularization for the treatment of end-stage coronary artery disease. J Am Coll Cardiol (2003) 1.53

Airway remodeling in subjects with severe asthma with or without chronic persistent airflow obstruction. J Allergy Clin Immunol (2009) 1.52

Differences in airway remodeling between subjects with severe and moderate asthma. J Allergy Clin Immunol (2005) 1.52

Effectiveness and safety of drug-eluting stents in vein grafts: a meta-analysis. Am Heart J (2010) 1.47

Long-term risk of ischemic stroke associated with rofecoxib. Cardiovasc Drugs Ther (2007) 1.46

In-hospital management of atrial fibrillation: the CHADS₂ score predicts increased cost. Can J Cardiol (2011) 1.46

Sex differences in acute coronary syndrome symptom presentation in young patients. JAMA Intern Med (2013) 1.45

Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes. J Allergy Clin Immunol (2006) 1.43

Application of the Seattle heart failure model in patients >80 years of age enrolled in a tertiary care heart failure clinic. Am J Cardiol (2012) 1.43

Effectiveness of statins for secondary prevention in elderly patients after acute myocardial infarction: an evaluation of class effect. CMAJ (2005) 1.43

Pulmonary arterial hypertension: pathophysiology and anesthetic approach. Anesthesiology (2003) 1.42

Acute vasodilator responsiveness and microvascular recruitment in idiopathic pulmonary arterial hypertension. Ann Intern Med (2015) 1.42

Hemodynamic stability after transitioning between endothelin receptor antagonists in patients with pulmonary arterial hypertension. Can J Cardiol (2012) 1.42

Bronchodilator use and the risk of arrhythmia in COPD: part 2: reassessment in the larger Quebec cohort. Chest (2012) 1.42

Addition of frailty and disability to cardiac surgery risk scores identifies elderly patients at high risk of mortality or major morbidity. Circ Cardiovasc Qual Outcomes (2012) 1.41

Increased expression of ADAM33 and ADAM8 with disease progression in asthma. J Allergy Clin Immunol (2007) 1.40

Comparing invasive and noninvasive management strategies for acute myocardial infarction using administrative databases. Am Heart J (2008) 1.40

Lack of benefit for routine functional testing early after coronary artery bypass graft surgery: results from the ROSETTA-CABG Registry. J Invasive Cardiol (2006) 1.40

Differences in airway cytokine profile in severe asthma compared to moderate asthma. Chest (2007) 1.36

Implementing practice guidelines: a workshop on guidelines dissemination and implementation with a focus on asthma and COPD. Can Respir J (2006) 1.32

Efficacy and safety of novel oral anticoagulants for treatment of acute venous thromboembolism: direct and adjusted indirect meta-analysis of randomised controlled trials. BMJ (2012) 1.28

Delays to reperfusion therapy in acute ST-segment elevation myocardial infarction: results from the AMI-QUEBEC Study. CMAJ (2006) 1.27

Proton pump inhibitors and the risk of hospitalisation for community-acquired pneumonia: replicated cohort studies with meta-analysis. Gut (2013) 1.26

Geographic and gender variability in the prevalence of bronchial responsiveness in Canada. Chest (2004) 1.26

CNODES: the Canadian Network for Observational Drug Effect Studies. Open Med (2012) 1.26

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol (2008) 1.21

Chronic inflammatory diseases and cardiovascular risk: a systematic review. Can J Cardiol (2011) 1.21

Behavioural interventions for smoking cessation: a meta-analysis of randomized controlled trials. Eur Heart J (2008) 1.20

Drug prescriptions after acute myocardial infarction: dosage, compliance, and persistence. Am Heart J (2003) 1.20

In-hospital cost of total hip arthroplasty in Canada and the United States. J Bone Joint Surg Am (2004) 1.19

Prevalence of obstructive sleep apnea-hypopnea in severe versus moderate asthma. J Allergy Clin Immunol (2009) 1.18

Anemia and mortality in acute coronary syndromes: a systematic review and meta-analysis. Am Heart J (2012) 1.17

Isolated aerobic exercise and weight loss: a systematic review and meta-analysis of randomized controlled trials. Am J Med (2011) 1.16

Childhood predictors of smoking in adolescence: a follow-up study of Montreal schoolchildren. CMAJ (2005) 1.16

Bias in observational study of the effectiveness of nasal corticosteroids in asthma. J Allergy Clin Immunol (2005) 1.14

Risks of pneumonia in patients with asthma taking inhaled corticosteroids. Am J Respir Crit Care Med (2010) 1.12

Effect of fibrates on lipid profiles and cardiovascular outcomes: a systematic review. Am J Med (2009) 1.11

Beneficial effects of right ventricular non-apical vs. apical pacing: a systematic review and meta-analysis of randomized-controlled trials. Europace (2011) 1.11

Coronary artery perforation during percutaneous coronary intervention: a systematic review and meta-analysis. Can J Cardiol (2011) 1.10

Implementation of a targeted screening program to detect airflow obstruction suggestive of chronic obstructive pulmonary disease within a presurgical screening clinic. Can Respir J (2015) 1.09

ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents developed in collaboration with the American Academy of Neurology, American Geriatrics Society, American Society for Preventive Cardiology, American Society of Hypertension, American Society of Nephrology, Association of Black Cardiologists, and European Society of Hypertension. J Am Soc Hypertens (2011) 1.09

Second reading of coronary angiograms by radiologists. Can J Cardiol (2006) 1.08

Inhaled and nasal corticosteroid use and the risk of fracture. Am J Respir Crit Care Med (2003) 1.07

Electronic cigarettes in North America: history, use, and implications for smoking cessation. Circulation (2014) 1.06